halofuginone has been researched along with Osteoporosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deselm, CJ; Teitelbaum, SL; Zou, W | 1 |
1 other study(ies) available for halofuginone and Osteoporosis
Article | Year |
---|---|
Halofuginone prevents estrogen-deficient osteoporosis in mice.
Topics: Animals; Body Weight; Bone Density Conservation Agents; Bone Resorption; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Evaluation, Preclinical; Estrogens; Interleukin-17; Mice; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; Piperidines; Quinazolinones; RANK Ligand | 2012 |